Results 31 to 40 of about 101 (77)

Fungal diagnostics and antifungal drug access in Latin America and the Caribbean: an ESCMID EFISG multinational survey. [PDF]

open access: yesNat Commun
Pasqualotto AC   +16 more
europepmc   +1 more source

Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study. [PDF]

open access: yesOncologist
García-Alfonso P   +21 more
europepmc   +1 more source

Ten-Year Outcomes in Colorectal Cancer-Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study. [PDF]

open access: yesJ Clin Med
García-Aranda M   +12 more
europepmc   +1 more source

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study. [PDF]

open access: yesJ Clin Oncol, 2019
Carmona-Bayonas A   +28 more
europepmc   +1 more source

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer. [PDF]

open access: yesBMC Cancer, 2019
Sarasqueta C   +10 more
europepmc   +1 more source

Strengthening Fungal Infection Diagnosis and Treatment: An In-depth Analysis of Capabilities in Honduras. [PDF]

open access: yesOpen Forum Infect Dis
Ortiz B   +5 more
europepmc   +1 more source

Impact of errors of creatinine and cystatin C equations in the selection of living kidney donors. [PDF]

open access: yesClin Kidney J, 2019
González-Rinne A   +19 more
europepmc   +1 more source

Colorectal cancer health services research study protocol: the CCR-CARESS observational prospective cohort project. [PDF]

open access: yesBMC Cancer, 2016
Quintana JM   +11 more
europepmc   +1 more source

Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study. [PDF]

open access: yesBMC Cancer, 2018
Fernández A   +25 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy